| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 1, 2006
Accepted on January 3, 2007
Center for Ulcer Research and Education, Digestive Diseases Research Center and Center for Neurovisceral Sciences and Women's Health, Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, UCLA, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073. Division of Gastroenterology, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan
* To whom correspondence should be addressed. E-mail: vwu{at}ucla.edu.
The rat esophagus shares some cellular features with skin squamous epithelium and striated muscle that express high levels of CRF2 receptors or their cognate ligand urocortins (Ucn). We investigated the expression and cell signaling of CRF2 receptors and ligands in the rat esophagus and lower esophageal sphincter (LES) by reverse transcriptase-PCR and quantitative PCR in normal and corticosterone-treated whole esophageal tissue, laser capture microdissected layers, and isolated esophageal cells. The expression of CRF2 receptor protein and intracellular cAMP and ERK1/2 responses to CRF agonists and CRF2 antagonist were determined in cultured esophageal cells and HEK-293 cells transfected with CRF2b receptors. CRF2 was abundantly expressed in the mucosa and longitudinal muscle layers of the esophagus and LES while CRF1 expression was scarce. CRF2b wild-type transcript was predominantly expressed in the esophagus and, in addition, several new CRF2 splice variants including six CRF2a isoforms were identified. Expression of Ucn 1, Ucn 2 and to a smaller extent, Ucn 3, but not CRF mRNA was detected in the esophagus and LES. Ucn 1 and Ucn 2 stimulated dose-dependent cAMP production and ERK1/2 phosphorylation in the esophageal cells, while CRF and CRF1 agonist, cortagine, had less potent effects. In addition, Ucn 2-stimulated cAMP and ERK responses were blocked by the CRF2 antagonist, astressin2-B. These data established the presence of a prominent CRF2 signaling system in the esophagus and LES encompassing multiple CRF2 receptor variants and urocortins, suggesting a functional role in secreto-motor activity, and epithelial and muscle cell proliferation.
This article has been cited by other articles:
![]() |
C H Knowles and Q Aziz Visceral hypersensitivity in non-erosive reflux disease Gut, May 1, 2008; 57(5): 674 - 683. [Full Text] [PDF] |
||||
![]() |
G. Gourcerol, L. Wang, Y. H. Wang, M. Million, and Y. Tache Urocortins and Cholecystokinin-8 Act Synergistically to Increase Satiation in Lean But Not Obese Mice: Involvement of Corticotropin-Releasing Factor Receptor-2 Pathway Endocrinology, December 1, 2007; 148(12): 6115 - 6123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Soderholm Stress-related changes in oesophageal permeability: filling the gaps of GORD? Gut, September 1, 2007; 56(9): 1177 - 1180. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |